These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 27943498)

  • 1. Risk factors for the development of Clostridium difficile infection in adult allogeneic hematopoietic stem cell transplant recipients: A single-center study in Québec, Canada.
    Lavallée C; Labbé AC; Talbot JD; Alonso CD; Marr KA; Cohen S; Laverdière M; Dufresne SF
    Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27943498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors and epidemiology of Clostridium difficile infection in hematopoietic stem cell transplant recipients during the peritransplant period.
    Aldrete SD; Kraft CS; Magee MJ; Chan A; Hutcherson D; Langston AA; Greenwell BI; Burd EM; Friedman-Moraco R
    Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27943501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Risk Factors for Clostridium difficile Infection in Hematopoietic Stem Cell Transplant Recipients.
    Scardina TL; Kang Martinez E; Balasubramanian N; Fox-Geiman M; Smith SE; Parada JP
    Pharmacotherapy; 2017 Apr; 37(4):420-428. PubMed ID: 28226419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome.
    Willems L; Porcher R; Lafaurie M; Casin I; Robin M; Xhaard A; Andreoli AL; Rodriguez-Otero P; Dhedin N; Socié G; Ribaud P; Peffault de Latour R
    Biol Blood Marrow Transplant; 2012 Aug; 18(8):1295-301. PubMed ID: 22387347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clostridioides difficile Infection and Risk of Acute Graft-versus-Host Disease among Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
    Jabr R; El Atrouni W; Shune L; Telfah M; Gao G; He J; Abhyankar S; McGuirk J; Clough L
    Transplant Cell Ther; 2021 Feb; 27(2):176.e1-176.e8. PubMed ID: 33830032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients.
    Alonso CD; Treadway SB; Hanna DB; Huff CA; Neofytos D; Carroll KC; Marr KA
    Clin Infect Dis; 2012 Apr; 54(8):1053-63. PubMed ID: 22412059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus infection and disease after allogeneic hematopoietic stem cell transplantation: experience in a center with a high seroprevalence of both CMV and hepatitis B virus.
    Liu YC; Lu PL; Hsiao HH; Chang CS; Liu TC; Yang WC; Lin SF
    Ann Hematol; 2012 Apr; 91(4):587-95. PubMed ID: 21997849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clostridium difficile infection in the hematopoietic unit: a meta-analysis of published studies.
    Zacharioudakis IM; Ziakas PD; Mylonakis E
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1650-4. PubMed ID: 24914822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy.
    George B; Pati N; Gilroy N; Ratnamohan M; Huang G; Kerridge I; Hertzberg M; Gottlieb D; Bradstock K
    Transpl Infect Dis; 2010 Aug; 12(4):322-9. PubMed ID: 20487414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Clostridium difficile infection during allogeneic hematopoietic stem cell transplantation.
    Kinnebrew MA; Lee YJ; Jenq RR; Lipuma L; Littmann ER; Gobourne A; No D; van den Brink M; Pamer EG; Taur Y
    PLoS One; 2014; 9(3):e90158. PubMed ID: 24662889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with refractory cytomegalovirus (CMV) infection following allogeneic haematopoietic stem cell transplantation are at high risk for CMV disease and non-relapse mortality.
    Liu J; Kong J; Chang YJ; Chen H; Chen YH; Han W; Wang Y; Yan CH; Wang JZ; Wang FR; Chen Y; Zhang XH; Xu LP; Liu KY; Huang XJ
    Clin Microbiol Infect; 2015 Dec; 21(12):1121.e9-15. PubMed ID: 26093077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
    Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
    Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of a positive Clostridium difficile toxin test after hematopoietic stem cell transplantation.
    Akahoshi Y; Kimura S; Nakano H; Harada N; Kameda K; Ugai T; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Sato M; Terasako-Saito K; Nakasone H; Kikuchi M; Yamazaki R; Kanda J; Kako S; Nishida J; Kanda Y
    Clin Transplant; 2016 Jun; 30(6):703-8. PubMed ID: 27019071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive pneumococcal disease following adult allogeneic hematopoietic stem cell transplantation.
    Torda A; Chong Q; Lee A; Chen S; Dodds A; Greenwood M; Larsen S; Gilroy N
    Transpl Infect Dis; 2014 Oct; 16(5):751-9. PubMed ID: 25040633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence, course, and outcome of Clostridium difficile infection in children with hematological malignancies or undergoing hematopoietic stem cell transplantation.
    Salamonowicz M; Ociepa T; Frączkiewicz J; Szmydki-Baran A; Matysiak M; Czyżewski K; Wysocki M; Gałązka P; Zalas-Więcek P; Irga-Jaworska N; Drożyńska E; Zając-Spychała O; Wachowiak J; Gryniewicz-Kwiatkowska O; Czajńska-Deptuła A; Dembowska-Bagińska B; Chełmecka-Wiktorczyk L; Balwierz W; Bartnik M; Zielezińska K; Urasiński T; Tomaszewska R; Szczepański T; Płonowski M; Krawczuk-Rybak M; Pierlejewski F; Młynarski W; Gamrot-Pyka Z; Woszczyk M; Małas Z; Badowska W; Urbanek-Dądela A; Karolczyk G; Stolpa W; Sobol-Milejska G; Zaucha-Prażmo A; Kowalczyk J; Goździk J; Gorczyńska E; Jermakow K; Król A; Chybicka A; Ussowicz M; Kałwak K; Styczyński J
    Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1805-1812. PubMed ID: 29978303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clostridium difficile colonization and disease in patients undergoing hematopoietic stem cell transplantation.
    Bruminhent J; Wang ZX; Hu C; Wagner J; Sunday R; Bobik B; Hegarty S; Keith S; Alpdogan S; Carabasi M; Filicko-O'Hara J; Flomenberg N; Kasner M; Outschoorn UM; Weiss M; Flomenberg P
    Biol Blood Marrow Transplant; 2014 Sep; 20(9):1329-34. PubMed ID: 24792871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical and economic impact of cytomegalovirus infection in recipients of hematopoietic stem cell transplantation.
    Webb BJ; Harrington R; Schwartz J; Kammerer J; Spalding J; Lee E; Dodds B; Kaufusi S; Goodman BE; Firth SD; Martin G; Sorensen J; Hoda D
    Transpl Infect Dis; 2018 Oct; 20(5):e12961. PubMed ID: 29975816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral Vancomycin Prophylaxis as Secondary Prevention Against Clostridioides difficile Infection in the Hematopoietic Stem Cell Transplantation and Hematologic Malignancy Population.
    Morrisette T; Van Matre AG; Miller MA; Mueller SW; Bajrovic V; Abidi MZ; Benamu E; Kaiser JN; Barber GR; Chase S; Tobin J; Fish DN; Gutman JA
    Biol Blood Marrow Transplant; 2019 Oct; 25(10):2091-2097. PubMed ID: 31255741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case-Control Study of Inflammatory Bowel Disease Patients with and without Clostridium difficile Infection and Poor Outcomes in Patients Coinfected with C. difficile and Cytomegalovirus.
    Li Y; Xu H; Xu T; Xiao M; Tang H; Wu D; Tan B; Li J; Yang H; Lv H; Xu Y; Qian J
    Dig Dis Sci; 2018 Nov; 63(11):3074-3083. PubMed ID: 30094621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.